Delsie Braganza

Delsie joined the Focal Point Research team in 2011 and has been an invaluable asset for our clients. With her strong regulatory and quality assurance background, she is able to help clients understand the Canadian and US requirements, set targets to achieve compliance, and attain their goals to get products to market.

Delsie is able to audit facilities, set up and maintain GMP compliant facilities, develop strong quality management systems, and co-ordinate successful Health Canada inspections. In addition to this, Delsie oversees all regulatory compliance reviews and submissions made to Health Canada and the US FDA.

Delsie obtained an Honours Bachelor of Science (Hons. B. Sc.) in Pharmaceutical Chemistry from the University of Toronto, Post-Graduate Certificate in Pharmaceutical Regulatory Affairs and Quality Operations (RAQ) from Seneca College and Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professional Society (RAPS).

When she’s not learning something new, Delsie loves spending time with family, going on road trips or long walks, and swimming.

Articles

If you would like to be added to our newsletter, please send an email to mail@focalpointresearch.net with the subject line ‘Receive FPR Newsletter’.

Microbeads in Toiletries Regulations

Sep 4, 2019

On July 1st, 2019, the full Canadian prohibition on Microbeads in Toiletries came into effect for cosmetic products as well as natural and non-prescription products. As a result, regulatory officials may be kickstarting an enforcement program to ensure companies are...

California Senate Passes Cosmetics Fragrance Disclosure Bill

Aug 30, 2019

California's Senate has recently approved a bill to require cosmetic manufacturers to disclose fragrances or flavours of concern on their label. The Fragrance and Flavour Ingredient Right to Know Act of 2019 is calling for expanding the disclosure requirements to...

Can Health Features on Devices Detect Dementia Signs?

Aug 21, 2019

Apple Inc. and pharmaceutical giant Eli Lilly have joined forces to conduct research on whether dementia and signs of cognitive decline can be detected via health features on the iPhone and Apple Watch. Evidation, a health tech startup, is also involved in the...

Sterigenics Makes Deal to Reopen Willowbrook Sterilization Plant

Jul 30, 2019

Following the shutdown of an Illinois Sterigenics plant in February of 2019, a deal has been made for it to be reopened, pending approval from the DuPage County Circuit Court. According to a Medtech Dive post, the closure of the Willowbrook plant caused losses of...

European Chemicals Agency (ECHA) Restricts Microplastics and Siloxanes

Jul 9, 2019

Intentionally Added Microplastics: Microplastics are manufactured and used in many products on the European market. These ‘intentional’ uses of microplastics are the focus of the proposed restrictions. The potential posed environmental and human health risks of...

U.S.-China Tariff Increase Updates

May 21, 2019

The Office of the United States Trade Representative (USTR) formally published a notice in the Federal Register on May 10th of an increase in tariffs from 10% to 25% on all List 3 products being imported from China. The 10% Tariff remains in effect until June 1st for...

Can Sunscreen Absorption into the Bloodstream Pose Health Risks?

May 9, 2019

A pilot study recently published in the medical journal, JAMA, found that it took just one day of sunscreen use for several active ingredients in sunscreen products to enter the blood stream at high levels. The sunscreen absorption study, which was conducted by a...

Effects of Sterigenics Plant Shutdown on Medical Device Licences (MDL) in Canada

May 1, 2019

Sterigenics, an international company who provides sterilization solutions for medical devices, pharmaceutical, commercial, and food industries, has shut down its plant in Willowbrook, Illinois. The recent shutdown, which took place in February 2019, was linked to the...

Amway Launches 50 New Apps with New Digital Technology Model

Apr 24, 2019

Amway, an American multi-level marketing company that sells health, beauty, and home care products, has approached a new take on improving their business before outsider digital technology disrupts it. They recently teamed up with Texas-based software company, Kony,...

New Self-Care Framework Timeline

Apr 17, 2019

Health Canada is working towards improving the way self-care products (cosmetics, NHPs, and non-prescription drugs) are regulated in Canada. These changes will be implemented via the “Self-Care Framework” to regulate low-risk self care products in the same way, and...

« Older Entries

Next Entries »

“Focal Point Research has consistently and professionally looked after regulatory and quality issues of our brand for years. Through a courteous and knowledgeable team, they have managed to navigate us through an ever changing regulatory landscape while maintaining our interests, and allowed us to correctly distribute and sell within Canada.”

“I have truly enjoyed working with you over the last 8 years! You and your team have been an amazing resource for me. I have always been impressed by the knowledge and professionalism of everyone at Focal Point, which is a true testament to your leadership.”

Connect With Us

The Focal Point Research team is ready to help with all of your scientific and regulatory needs. Our team has the experience and expertise you need to see your product to market and we are eager to help you.

181 Lakeshore Road E. Mississauga, ON

1 (905) 271 2709

mail@focalpointresearch.net

Delsie Braganza

Jennifer Porter, BA Psychology, MBA – President & CEO

Articles

If you would like to be added to our newsletter, please send an email to mail@focalpointresearch.net with the subject line ‘Receive FPR Newsletter’.

Connect With Us